share_log

康希諾生物:海外監管公告

CANSINOBIO: Overseas regulatory announcement.

HKEX ·  Dec 20 18:47

Summary by Futu AI

康希諾生物股份公司的部分控股股東、實際控制人及其一致行動人完成增持公司H股股份計劃。根據北京市競天公誠律師事務所出具的法律意見書,本次增持符合《上市公司收購管理辦法》規定的免於發出要約的情形。增持人包括公司董事長兼總經理XUEFENG YU(宇學峰)、副總經理朱濤,以及執行董事SHOU BAI CHAO(巢守柏)。本次增持期間,三人累計增持公司278,000股H股,約佔公司總股本的0.1123%。增持完成後,XUEFENG YU持股比例升至7.2638%,朱濤升至7.2678%,SHOU BAI CHAO新增持股0.0275%。律師認為,增持人具備實施本次增持的主體資格,增持行為符合相關法律法規規定。由於公司控股股東、實際控制人合計持股比例持續超過30%,且本次增持未超過公司已發行股份的2%,因此可免於發出要約。公司已就本次增持履行了現階段所需的相關信息披露義務。
康希諾生物股份公司的部分控股股東、實際控制人及其一致行動人完成增持公司H股股份計劃。根據北京市競天公誠律師事務所出具的法律意見書,本次增持符合《上市公司收購管理辦法》規定的免於發出要約的情形。增持人包括公司董事長兼總經理XUEFENG YU(宇學峰)、副總經理朱濤,以及執行董事SHOU BAI CHAO(巢守柏)。本次增持期間,三人累計增持公司278,000股H股,約佔公司總股本的0.1123%。增持完成後,XUEFENG YU持股比例升至7.2638%,朱濤升至7.2678%,SHOU BAI CHAO新增持股0.0275%。律師認為,增持人具備實施本次增持的主體資格,增持行為符合相關法律法規規定。由於公司控股股東、實際控制人合計持股比例持續超過30%,且本次增持未超過公司已發行股份的2%,因此可免於發出要約。公司已就本次增持履行了現階段所需的相關信息披露義務。
CANSINOBIO's major controlling shareholders, actual controllers and their concerted action persons have completed their plan to increase shareholding in the company's H shares. According to the legal opinion issued by Peking Jing Tian Public Interest Law Firm, this increase complies with the regulations of the "Management Measures for the Acquisition of Listed Companies" and is exempt from the requirement to make an offer.The purchasers include the company's Chairman and General Manager XUEFENG YU, Vice General Manager ZHU TAO, and Executive Director SHOU BAI CHAO. During the shareholding increase period, the three individuals cumulatively acquired 278,000 H shares, accounting for approximately 0.1123% of the company's total equity. After the increase, XUEFENG YU's shareholding ratio rose to 7.2638%, ZHU...Show More
CANSINOBIO's major controlling shareholders, actual controllers and their concerted action persons have completed their plan to increase shareholding in the company's H shares. According to the legal opinion issued by Peking Jing Tian Public Interest Law Firm, this increase complies with the regulations of the "Management Measures for the Acquisition of Listed Companies" and is exempt from the requirement to make an offer.The purchasers include the company's Chairman and General Manager XUEFENG YU, Vice General Manager ZHU TAO, and Executive Director SHOU BAI CHAO. During the shareholding increase period, the three individuals cumulatively acquired 278,000 H shares, accounting for approximately 0.1123% of the company's total equity. After the increase, XUEFENG YU's shareholding ratio rose to 7.2638%, ZHU TAO's to 7.2678%, and SHOU BAI CHAO acquired an additional 0.0275% of shares.Lawyers believe that the purchasers have the qualification to carry out this increase and that the increase behavior complies with relevant laws and regulations. Since the combined shareholding ratio of the company's major shareholders and actual controllers remains above 30%, and this increase does not exceed 2% of the company's total issued shares, it is therefore exempt from making an offer. The company has fulfilled its relevant information disclosure obligations required at this stage regarding this shareholding increase.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.